Breakthrough Infection

Rheumatologists need to start focusing on their fully vaccinated patients with breakthrough COVID-19 cases, and begin referring them for monoclonal treatment, according to Leonard Calabrese, DO.

Approximately one-quarter of patients with hematologic malignancies did not produce measurable antibodies after two doses of COVID-19 vaccines, according to a study from The Leukemia & Lymphoma Society published in Cancer Cell.

CDC investigators identified just 10,262 breakthrough SARS-CoV-2 infections in 46 U.S. states as of April 30, when approximately 101 million Americans had been fully vaccinated, according to results published today in MMWR.